These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 21204288

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Practicing IEF-PAGE of EPO: the impact of detergents and sample application methods on analytical performance in doping control.
    Reichel C.
    Drug Test Anal; 2010; 2(11-12):603-19. PubMed ID: 21204292
    [Abstract] [Full Text] [Related]

  • 3. Easy-to-use IEF compatible immunoaffinity purification of Erythropoietin from urine retentates.
    Reihlen P, Völker-Schänzer E, Majer B, Schänzer W.
    Drug Test Anal; 2012 Nov; 4(11):813-7. PubMed ID: 22566398
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.
    Desharnais P, Naud JF, Ayotte C.
    Drug Test Anal; 2013 Nov; 5(11-12):870-6. PubMed ID: 23720238
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application.
    Okano M, Sato M, Kaneko E, Kageyama S.
    Drug Test Anal; 2011 Nov; 3(11-12):798-805. PubMed ID: 22012825
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE.
    Postnikov P, Krotov G, Mesonzhnik N, Efimova Y, Rodchenkov G.
    Drug Test Anal; 2015 Nov; 7(11-12):999-1008. PubMed ID: 26695487
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recent developments in doping testing for erythropoietin.
    Reichel C.
    Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Determination methods for erythropoietin receptor activator in human urine].
    Xing YY, Zhang LS, Xu YX, Wu MT, Wang S.
    Yao Xue Xue Bao; 2009 Jul; 44(7):820-3. PubMed ID: 19806926
    [Abstract] [Full Text] [Related]

  • 18. Defending Dynepo detection.
    Gmeiner G, Reichel C, Kulovics R, Scheiblhofer V.
    Drug Test Anal; 2010 Jul; 2(11-12):526-32. PubMed ID: 21204285
    [Abstract] [Full Text] [Related]

  • 19. Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters.
    Dehnes Y, Hemmersbach P.
    Drug Test Anal; 2011 May; 3(5):291-9. PubMed ID: 21387570
    [Abstract] [Full Text] [Related]

  • 20. An optimized SDS-PAGE protocol with a new blotting system for the initial testing procedure of ESAs in doping control.
    Martin L, Martin JA, Audran M, Marchand A.
    Drug Test Anal; 2022 Jan; 14(1):181-187. PubMed ID: 33269539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.